Last month in Amsterdam, The Netherlands, on April 25-26, the eyeforpharma 5th Annual Real World Evidence Europe conference was attended with around 250 pharma industry leaders, payers, and subject matter experts. The conference agenda was comprised of current challenges, latest innovations and future trends in RWE, a subject of great interest to many key stakeholders in drug development.
The two-day event saw speakers grappling with important ideas centered around RWE including the necessity for cross-functional working within companies; patient centricity; value-based outcomes for healthcare systems; the challenges related to RWE terminology; challenges regarding reimbursement and payment models; the practical application of cross-functional working in RWE; and much more.
View a detailed report on the conference here.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.